Plasma exosome role in thinking problems in first-episode schizophrenia
Part of Mental health clinical trials.
This study looks at tiny particles called exosomes in your blood and how small molecules inside them called microRNAs may affect thinking and memory in people with a first episode of schizophrenia. If you join, your blood will be used to help find new ways to understand and treat cognitive symptoms.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You or a healthy volunteer matched by sex, age, and education level.
- No family history of psychiatric disorders in parents, siblings, or grandparents.
- You must be of Han Chinese ethnicity.
- No serious physical illnesses like uncontrolled high blood pressure, heart disease, diabetes, or epilepsy.
- Not currently or previously diagnosed with a substance-induced psychotic disorder, delusional disorder, brief psychotic disorder, or mood disorder with psychotic features.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at how a natural chemical pathway in the body might relate to thinking problems in people with schizophrenia. It compares healthy volunteers to people with schizophrenia to find biological clues.
This study looks at how psychiatric and neurological conditions affect thinking and memory skills. By comparing patients with healthy volunteers, researchers hope to better understand these cognitive problems and find new ways to help.
This study looks at neurofilament light (a brain/nerve injury marker) and how it relates to thinking and memory problems in people with certain psychiatric conditions. It may help researchers understand brain changes and cognitive impairment, which could guide better diagnosis in the future.
This study looks at brain chemicals involved in “glutamate” and “GABA” signaling in people with schizophrenia (and separately in healthy volunteers). It may help researchers understand what’s going wrong in the brain and guide future treatments.
This study investigates how much mental effort people with psychotic disorders (like schizophrenia) use during thinking tests, compared to people without mental health conditions. It may help researchers better understand cognitive challenges in these disorders.
This study builds a database of brain-signal measurements to help find “biomarkers” that may point to schizophrenia or related mental illnesses. Depending on whether you have a mental health diagnosis or you’re healthy, the study will collect information and brain data to compare groups.
Hear when a new Schizophrenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.